Estrella Immunopharma, Inc. (ESLA) vs Kyntra Bio Inc (KYNB)
- Estrella Immunopharma, Inc. ESLA 0.43 −20.37%
- Kyntra Bio Inc KYNB 4.85 −9.51%
Estrella Immunopharma, Inc. and Kyntra Bio Inc are both Biotechnology companies. Estrella Immunopharma, Inc. and Kyntra Bio Inc are of similar size ($23.3M and $21.7M). Estrella Immunopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Estrella Immunopharma, Inc. leads on 5 and Kyntra Bio Inc on 5.
Valuation
Profitability
| Metric | ESLA | KYNB | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 6.28% | 65.16% |
| Operating margin | 0.00% | (1,089.78%) | 0.00% |
| Net margin | 0.00% | 3,967.77% | 0.00% |
| Free cash flow margin | 0.00% | (824.19%) | 0.00% |
| Return on equity | 148.05% | (157.83%) | (56.36%) |
| Return on assets | (416.74%) | 131.26% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack